Agitation
Understanding agitation, restlessness, irritability, and hostility in a clinical setting is crucial for accurate diagnosis and treatment. This resource provides information on identifying, documenting, and coding agitation (ICD-10) for healthcare professionals, including physicians, nurses, and medical coders. Learn about assessing and managing agitation symptoms, plus exploring related terms like psychomotor agitation and differential diagnoses for improved patient care and accurate medical records.
A state of anxiety, restlessness, and emotional unease.
Pacing, fidgeting, irritability, raised voice, difficulty concentrating.
Hospital delirium, dementia, psychiatric disorders, substance withdrawal.
ICD-10 Code Families
Complete code families applicable to R45.1
When to use each related code
| Description | When to use |
|---|---|
| Feeling restless, tense, or irritable. | Patient exhibits excessive motor activity, emotional distress, or uncharacteristic anger. Consider severity and context. |
| Generalized Anxiety Disorder (GAD). | Excessive, persistent worry about various things for 6+ months, impacting daily life. Rule out other anxiety disorders. |
| Manic episode of bipolar disorder. | Elevated, expansive, or irritable mood with increased energy/activity lasting 1+ week. Significant functional impairment. |
Best-practice checklist
- ✓Document agitation severity (mild, moderate, severe)
- ✓Describe observable agitated behaviors (e.g., pacing, fidgeting)
- ✓Note agitation triggers or associated factors
- ✓Correlate agitation with underlying medical conditions if present
- ✓Specify duration and frequency of agitation episodes
Common pitfalls to avoid
Coding agitation without specifying underlying cause or clinical context can lead to inaccurate severity and reimbursement.
Agitation may be a symptom of other conditions. Miscoding it as a primary diagnosis can skew data and quality metrics.
Lack of detailed documentation supporting the agitation diagnosis can raise audit flags and result in claim denials.
Best-practice tips
- 01De-escalate: calm environment, active listening
- 02Identify triggers: document specific causes of agitation
- 03Non-pharmacological interventions: offer distractions, reassurance
- 04Medication review: assess for drug interactions or side effects
- 05Interprofessional team: consult psychiatry, social work for support
Step-by-step checklist
- 1
Review patient history for pre-existing anxiety, mood disorders, or dementia.
- 2
Assess vital signs, including heart rate, blood pressure, and temperature.
- 3
Evaluate medication list for potential drug interactions or adverse effects.
- 4
Screen for substance use or withdrawal symptoms using validated tools.
- 5
Document agitation level, triggers, and interventions in patient chart.
Ready-to-paste narrative
Patient presents with agitation, characterized by observable restlessness and increased motor activity. Symptoms include pacing, hand-wringing, and verbal irritability. Differential diagnosis includes anxiety, akathisia, delirium, and substance-induced agitation. Patient reports feeling on edge and unable to sit still. Assessment includes monitoring for escalating behaviors such as hostility and aggression. Current medications were reviewed for potential exacerbating factors. The patient's vital signs are within normal limits. Plan includes implementing de-escalation techniques, environmental modifications, and consideration of pharmacologic interventions for agitation management. Further evaluation will focus on identifying underlying causes and optimizing treatment strategies to reduce agitation symptoms and improve patient comfort and safety. ICD-10 code F48.9 for unspecified nonorganic anxiety disorder is provisionally assigned pending further diagnostic clarification. This documentation supports medical necessity for continued assessment and treatment of agitation.
Common questions and answers
What are the best evidence-based strategies for managing agitation in elderly patients with dementia?+
Managing agitation in elderly patients with dementia requires a multifaceted approach focusing on non-pharmacological interventions first. Start by identifying and addressing potential triggers like pain, infection, constipation, or environmental overstimulation. Consider implementing behavioral interventions such as a calming environment, structured activities, and personalized sensory stimulation. If these prove insufficient, explore pharmacological options judiciously, starting with low doses and carefully monitoring for side effects. Atypical antipsychotics may be considered in severe cases, but always weigh the risks and benefits, considering alternatives like mood stabilizers. Explore how a comprehensive care plan incorporating these strategies can improve patient outcomes and reduce caregiver burden. Learn more about specific dementia subtypes and their unique agitation management considerations.
How can I differentiate between delirium and agitation secondary to a psychiatric disorder in a hospitalized patient?+
Differentiating delirium and agitation due to a primary psychiatric disorder requires a thorough assessment encompassing medical history, physical examination, cognitive testing, and laboratory investigations. Delirium often presents with acute onset, fluctuating course, and impaired attention, while agitation related to a psychiatric condition may have a more gradual onset and stable presentation. Observe for signs of underlying medical conditions contributing to delirium, such as infections, metabolic disturbances, or medication side effects. A comprehensive review of medications, including recent changes or additions, is crucial. Consider implementing standardized tools like the Confusion Assessment Method (CAM) to aid in delirium diagnosis. If the cause of agitation remains unclear after initial assessment, consult with a psychiatrist or geriatrician for further evaluation. Explore how a multidisciplinary approach can facilitate accurate diagnosis and tailored intervention strategies.
What are the recommended first-line pharmacological treatments for agitation in patients with acute psychosis, considering potential risks and benefits?+
First-line pharmacological treatments for agitation in acute psychosis typically include second-generation antipsychotics (SGAs) like risperidone, olanzapine, or ziprasidone, due to their relatively lower risk of extrapyramidal side effects compared to first-generation antipsychotics (FGAs). Benzodiazepines like lorazepam can be used in conjunction with SGAs for rapid tranquilization, but their use should be short-term due to the risk of dependence and respiratory depression. Consider the patient's individual characteristics, including medical history and comorbidities, when choosing a medication. Closely monitor for potential side effects like metabolic syndrome, extrapyramidal symptoms, and sedation. Learn more about the comparative efficacy and safety profiles of different antipsychotics and consider implementing a shared decision-making approach with the patient and their family when discussing treatment options.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.